{"id":"W1975501001","doi":"10.1002/art.10870","title":"Anakinra, a recombinant human interleukin‐1 receptor antagonist (r‐metHuIL‐1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo‐controlled trial","year":2003,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":394,"is_retracted":false,"has_abstract":true,"ca_institutions":"Saint Paul University","funders":"","keywords":"Anakinra; Medicine; Placebo; Adverse effect; Discontinuation; Rheumatoid arthritis; Internal medicine; Placebo-controlled study; Population; Disease; Double blind; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001478406,0.0007526992,0.001858276,0.0008534016,0.0005083818,0.0003759338,0.0004541835,0.0002727472,0.0033396],"category_scores_gemma":[0.001096736,0.0006756783,0.0003874878,0.0005286452,0.0003846085,0.0008424429,0.0001422368,0.0009270923,0.0002838993],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003202208,"about_ca_system_score_gemma":0.0003026959,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004803859,"about_ca_topic_score_gemma":0.002695961,"domain_scores_codex":[0.9934289,0.0007397339,0.001929736,0.00108818,0.001371663,0.001441826],"domain_scores_gemma":[0.9972371,0.0002968836,0.0005622918,0.0008693197,0.0004634533,0.0005708823],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4630091,0.02133581,0.2556337,0.0001796901,0.002755707,0.0008448081,0.007024146,0.000007627287,0.0008736935,0.02077616,0.01520823,0.2123514],"study_design_scores_gemma":[0.9349122,0.004813691,0.01480768,0.008888555,0.000008894363,0.0001347275,0.00093386,0.0001041857,0.0002498836,0.0006351304,0.03356832,0.0009428429],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9767014,0.01020271,0.0001270677,0.0005132516,0.001710873,0.005971405,0.00009545776,0.0002227382,0.004455098],"genre_scores_gemma":[0.9341037,0.06121921,0.00206098,0.0002127401,0.00005189583,0.001303545,0.0003979743,0.0001485705,0.0005013956],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4719031,"threshold_uncertainty_score":0.9995694,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008667948685326339,"score_gpt":0.2612080628427256,"score_spread":0.2525401141573992,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}